Bachem Holding AG Bachem Holding AG

Bachem Holding AG

BANB

Classement en actions #2526
Bachem Holding AG serves pharmaceutical and biotechnology companies globally,... Bachem Holding AG serves pharmaceutical and biotechnology companies globally, providing products crucial for research, clinical development, and commercial use. The company's primary focus is on the design, manufacturing, and regulatory support for peptide active pharmaceutical ingredients (APIs), specifically targeting novel peptide and oligonucleotide chemical entities (NCEs). Additionally, Bachem offers commercially available NCEs and generic compounds. Its comprehensive service portfolio includes project management, quality assurance and regulatory guidance, analytical testing, production adhering to Good Manufacturing Practices (GMP), manufacturing for research purposes, and expertise in supply chain and vertical integration. Established in 1971, Bachem Holding AG is headquartered in Bubendorf, Switzerland, and functions as a subsidiary of Ingro Finanz AG.
Prix de l'action
$100.24
Capitalisation boursière
$7.51B
Changement (1 jour)
-1.84%
Changement (1 an)
48.99%
Pays
CH
Échange Bachem Holding AG (BANB)

Catégorie

Healthcare
Historique du prix de l'action pour Bachem Holding AG (BANB)
Prix de clôture le plus élevé : $105.12 le 2026-10-01

Prix de clôture le plus bas : $13.47 le 2001-03-01
Historique du prix de l'action de Bachem Holding AG de 2001 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 26.87%
2025 -3.05%
2024 -5.47%
2023 -16.69%
2022 -35.59%
2021 68.81%
2020 169.92%
2019 28.96%
2018 -16.46%
2017 68.14%
2016 64.94%
2015 3.94%
2014 -8.15%
2013 45.10%
2012 -0.04%
2011 -34.01%
2010 -12.09%
2009 -5.58%
2008 -20.36%
2007 13.73%
2006 32.09%
2005 1.28%
2004 12.61%
2003 11.00%
2002 -19.59%
2001 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$536.13 25.72%
US
$200.12 645.31%
US
$137.83 -3.78%
AU
$291.76 2.51%
BE
$880.01 8.09%
NL